Cerus Corporation(NASDAQ:CERS) 
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication is designed to reduce blood-borne pathogens in donated blood com...
Website: http://www.cerus.com
Founded: 1991
Full Time Employees: 254
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.25
H 1.28
L 1.19
C 1.24
V 1,655,640
10EMA 1.24
20EMA 1.24
60EMA 1.24
120EMA 1.24
250EMA 1.24